Terms: = Leukemia AND NAB2, MADER, 4665, ENSG00000166886, Q15742, MGC75085 AND Treatment
5 results:
1. Precision medicine: Statistical methods for estimating adaptive treatment strategies.
Moodie EEM; Krakow EF
Bone Marrow Transplant; 2020 Oct; 55(10):1890-1896. PubMed ID: 32286507
[TBL] [Abstract] [Full Text] [Related]
2. Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.
Lennmyr E; Karlsson K; Ahlberg L; Garelius H; Hulegårdh E; Izarra AS; Joelsson J; Kozlowski P; Moicean A; Tomaszewska-Toporska B; Lübking A; Hallböök H;
Eur J Haematol; 2019 Aug; 103(2):88-98. PubMed ID: 31074910
[TBL] [Abstract] [Full Text] [Related]
3. Outcomes of patients with childhood B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses: long-term follow-up of the ALLR3 open-label randomised trial.
Parker C; Krishnan S; Hamadeh L; Irving JAE; Kuiper RP; Révész T; Hoogerbrugge P; Hancock J; Sutton R; Moorman AV; Saha V
Lancet Haematol; 2019 Apr; 6(4):e204-e216. PubMed ID: 30826273
[TBL] [Abstract] [Full Text] [Related]
4. Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms.
Singh K; Sazawal S; Chhikara S; Mahapatra M; Saxena R
Indian J Pathol Microbiol; 2018; 61(3):371-374. PubMed ID: 30004057
[TBL] [Abstract] [Full Text] [Related]
5. p130Cas acts as survival factor during PMA-induced apoptosis in HL-60 promyelocytic leukemia cells.
Kumbrink J; Kirsch KH
Int J Biochem Cell Biol; 2013 Mar; 45(3):531-5. PubMed ID: 23287717
[TBL] [Abstract] [Full Text] [Related]
